Group 1 - The core collaboration between the company and Koser Medical focuses on the distribution of vascular interventional products, with an expected annual distribution scale of approximately 100 million yuan [1] - The actual implementation of the distribution business in 2026 may be influenced by factors such as channel expansion, indicating a degree of uncertainty [1]

Core Viewpoint - The company has entered into a distribution partnership with Koseir Medical, focusing on vascular intervention products, with an expected annual distribution scale of approximately 100 million yuan [1] Group 1 - The collaboration with Koseir Medical primarily involves the distribution of vascular intervention products [1] - The anticipated annual distribution scale from this partnership is around 100 million yuan [1] - The actual implementation of the distribution in 2026 may be influenced by factors such as channel expansion, introducing a degree of uncertainty [1]

Group 1 - The company is currently engaged in the distribution of medical surgical robot products [1] - The company does not involve in the manufacturing and distribution of brain-computer interface products [1]

Group 1 - The company, Jianfa Zhixin (301584.SZ), currently acts as a distributor for the Da Vinci surgical robot, which is owned by Intuitive Surgical, Inc. and is not developed or produced by the company [1] - The company has no current technological research and development reserves or investment plans in the field of medical robotics [1]

Core Viewpoint - The company, Jianfa Zhixin, clarified that it acts as a distributor for the Da Vinci surgical robot system, which is owned by Intuitive Surgical, Inc., and is not involved in its research and development [1] Company Information - Jianfa Zhixin confirmed that it does not have any technological research and development reserves or investment plans in the field of medical robots [1]